vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.
JBT Marel Corp is the larger business by last-quarter revenue ($1.0B vs $829.0M, roughly 1.2× Acadia Healthcare Company, Inc.). JBT Marel Corp runs the higher net margin — 5.3% vs 0.5%, a 4.7% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 7.5%). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
ACHC vs JBTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.0B |
| Net Profit | $4.5M | $53.1M |
| Gross Margin | — | 34.5% |
| Operating Margin | — | 7.2% |
| Net Margin | 0.5% | 5.3% |
| Revenue YoY | 7.5% | 115.6% |
| Net Profit YoY | -50.8% | 858.6% |
| EPS (diluted) | $0.05 | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $934.8M | ||
| Q1 25 | $770.5M | $854.1M | ||
| Q4 24 | $774.2M | $467.6M | ||
| Q3 24 | $815.6M | $453.8M | ||
| Q2 24 | $796.0M | $402.3M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $53.1M | ||
| Q3 25 | $36.2M | $66.0M | ||
| Q2 25 | $30.1M | $3.4M | ||
| Q1 25 | $8.4M | $-173.0M | ||
| Q4 24 | $32.6M | $-7.0M | ||
| Q3 24 | $68.1M | $38.9M | ||
| Q2 24 | $78.5M | $30.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 34.5% | ||
| Q3 25 | — | 35.9% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 34.2% | ||
| Q4 24 | — | 38.4% | ||
| Q3 24 | — | 36.1% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 7.2% | ||
| Q3 25 | 4.7% | 10.2% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | -3.9% | ||
| Q4 24 | 4.9% | 3.4% | ||
| Q3 24 | 12.1% | 10.3% | ||
| Q2 24 | 13.4% | 6.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 5.3% | ||
| Q3 25 | 4.3% | 6.6% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 1.1% | -20.3% | ||
| Q4 24 | 4.2% | -1.5% | ||
| Q3 24 | 8.4% | 8.6% | ||
| Q2 24 | 9.9% | 7.6% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.04 | ||
| Q3 25 | $0.40 | $1.26 | ||
| Q2 25 | $0.33 | $0.07 | ||
| Q1 25 | $0.09 | $-3.35 | ||
| Q4 24 | $0.36 | $-0.22 | ||
| Q3 24 | $0.74 | $1.21 | ||
| Q2 24 | $0.85 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $167.9M |
| Total DebtLower is stronger | $2.5B | $1.5B |
| Stockholders' EquityBook value | $2.0B | $4.5B |
| Total Assets | $5.5B | $8.2B |
| Debt / EquityLower = less leverage | 1.29× | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $167.9M | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | $1.2B | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.0B | $1.3B | ||
| Q3 24 | $1.9B | $648.3M | ||
| Q2 24 | $1.8B | $647.7M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $4.5B | ||
| Q3 25 | $3.1B | $4.4B | ||
| Q2 25 | $3.1B | $4.4B | ||
| Q1 25 | $3.0B | $4.1B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.6B | ||
| Q2 24 | $3.0B | $1.5B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $8.2B | ||
| Q3 25 | $6.4B | $8.2B | ||
| Q2 25 | $6.3B | $8.3B | ||
| Q1 25 | $6.1B | $8.0B | ||
| Q4 24 | $6.0B | $3.4B | ||
| Q3 24 | $5.9B | $2.8B | ||
| Q2 24 | $5.7B | $2.7B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.33× | ||
| Q3 25 | 0.74× | 0.34× | ||
| Q2 25 | 0.74× | 0.35× | ||
| Q1 25 | 0.72× | 0.48× | ||
| Q4 24 | 0.64× | 0.81× | ||
| Q3 24 | 0.62× | 0.41× | ||
| Q2 24 | 0.62× | 0.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $117.4M |
| Free Cash FlowOCF − Capex | — | $83.5M |
| FCF MarginFCF / Revenue | — | 8.3% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | 13.78× | 2.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $117.4M | ||
| Q3 25 | $73.2M | $87.7M | ||
| Q2 25 | $133.5M | $102.2M | ||
| Q1 25 | $11.5M | $34.4M | ||
| Q4 24 | $116.7M | $128.7M | ||
| Q3 24 | $163.1M | $71.9M | ||
| Q2 24 | $171.1M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $83.5M | ||
| Q3 25 | $-63.0M | $56.5M | ||
| Q2 25 | $-34.2M | $83.7M | ||
| Q1 25 | $-163.2M | $14.4M | ||
| Q4 24 | $-86.8M | $118.7M | ||
| Q3 24 | $-27.1M | $65.0M | ||
| Q2 24 | $16.9M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 8.3% | ||
| Q3 25 | -7.4% | 5.6% | ||
| Q2 25 | -3.9% | 9.0% | ||
| Q1 25 | -21.2% | 1.7% | ||
| Q4 24 | -11.2% | 25.4% | ||
| Q3 24 | -3.3% | 14.3% | ||
| Q2 24 | 2.1% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.4% | ||
| Q3 25 | 16.0% | 3.1% | ||
| Q2 25 | 19.3% | 2.0% | ||
| Q1 25 | 22.7% | 2.3% | ||
| Q4 24 | 26.3% | 2.1% | ||
| Q3 24 | 23.3% | 1.5% | ||
| Q2 24 | 19.4% | 2.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.21× | ||
| Q3 25 | 2.02× | 1.33× | ||
| Q2 25 | 4.43× | 30.06× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 1.85× | ||
| Q2 24 | 2.18× | 0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
JBTM
Segment breakdown not available.
